Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells-Reference-Cited by-同舟云学术

Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells

Published:2009-02 Issue:2 Volume:274 Page:327-330
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Önyüksel Hayat,Jeon Eunjung,Rubinstein Israel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents;Boumendjel;Med. Res. Rev.,2005

2. Multidrug resistance in cancer: role of ATP-dependent transporters;Gottesman;Nat. Rev. Cancer,2002

3. Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporine;Theis;Int. J. Clin. Pharmacol. Ther.,1998

4. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues;Thiebaut;Proc. Natl. Acad. Sci. USA,1987

5. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells;Carrion;Life Sci.,2004

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of polymeric micelles for targeted therapeutic delivery;Nano Today;2024-04

2. Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions;Journal of Drug Delivery Science and Technology;2023-06

3. Nanotechnology in Cancer Chemoprevention: In Vivo and In Vitro Studies and Advancement in Biological Sciences;Modern Nanotechnology;2023

4. Synthesis and anticancer properties of dendritic glycoconjugates containing multiple o-carborane clusters;New Journal of Chemistry;2023

5. Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications;Pharmaceutical Fronts;2022-06